Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants-Reference-Cited by-同舟云学术

Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants

Published:2006-03-19 Issue:4 Volume:12 Page:417-424
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

van Hall Thorbald,Wolpert Elisabeth Z,van Veelen Peter,Laban Sandra,van der Veer Michael,Roseboom Marjet,Bres Sandra,Grufman Per,de Ru Arnoud,Meiring Hugo,de Jong Ad,Franken Kees,Teixeira Antoinette,Valentijn Rob,Drijfhout Jan Wouter,Koning Frits,Camps Marcel,Ossendorp Ferry,Kärre Klas,Ljunggren Hans-Gustaf,Melief Cornelis J M,Offringa Rienk

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1381.pdf

Reference38 articles.

1. Melief, C.J. et al. Strategies for immunotherapy of cancer. Adv. Immunol. 75, 235–282 (2000).

2. Khong, H.T. & Restifo, N.P. Natural selection of tumor variants in the generation of “tumor escape” phenotypes. Nat. Immunol. 3, 999–1005 (2002).

3. Hicklin, D.J., Marincola, F.M. & Ferrone, S. HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. Mol. Med. Today 5, 178–186 (1999).

4. Seliger, B., Maeurer, M.J. & Ferrone, S. TAP off–tumors on. Immunol. Today 18, 292–299 (1997).

5. Marincola, F.M., Jaffee, E.M., Hicklin, D.J. & Ferrone, S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv. Immunol. 74, 181–273 (2000).

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination against neoantigens induced in cross-priming cDC1 in vivo;Cancer Immunology, Immunotherapy;2024-01

2. Transcriptome-based identification of tumor-reactive and bystander CD8 ⁺ T cell receptor clonotypes in human pancreatic cancer;Science Translational Medicine;2023-11-15

3. The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells;Molecular Cancer;2023-08-30

4. TAP-ing into the cross-presentation secrets of dendritic cells;Current Opinion in Immunology;2023-08

5. Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab;Nature Cancer;2023-04-10